Avicanna Inc (AVCN) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.017x

Based on the latest financial reports, Avicanna Inc (AVCN) has a cash flow conversion efficiency ratio of -0.017x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CA$-191.05K ≈ $-138.21K USD) by net assets (CA$11.39 Million ≈ $8.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Avicanna Inc - Cash Flow Conversion Efficiency Trend (2016–2025)

This chart illustrates how Avicanna Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read AVCN total debt and obligations for a breakdown of total debt and financial obligations.

Avicanna Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Avicanna Inc ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Income Asset Management Group Ltd AU:IAM	-2.381x
Decade Resources Ltd V:DEC	-0.028x
Berkah Beton Sadaya Tbk PT JK:BEBS	0.001x
PT Mitra Pack Tbk JK:PTMP	-0.087x
Trust Stamp Inc NASDAQ:IDAI	-0.325x
Thanasiri Group Public Company Limited BK:THANA	0.024x
Trematon Capital Investments JSE:TMT	0.068x
Euro Manganese Inc AU:EMN	3.412x

Annual Cash Flow Conversion Efficiency for Avicanna Inc (2016–2025)

The table below shows the annual cash flow conversion efficiency of Avicanna Inc from 2016 to 2025. For the full company profile with market capitalisation and key ratios, see how much is Avicanna Inc worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CA$11.39 Million ≈ $8.24 Million	CA$-1.18 Million ≈ $-854.49K	-0.104x	+60.32%
2024-12-31	CA$9.74 Million ≈ $7.05 Million	CA$-2.55 Million ≈ $-1.84 Million	-0.261x	-48.44%
2023-12-31	CA$7.97 Million ≈ $5.77 Million	CA$-1.40 Million ≈ $-1.02 Million	-0.176x	+91.81%
2022-12-31	CA$3.46 Million ≈ $2.50 Million	CA$-7.44 Million ≈ $-5.38 Million	-2.150x	-27.33%
2021-12-31	CA$6.91 Million ≈ $5.00 Million	CA$-11.66 Million ≈ $-8.44 Million	-1.688x	-68.10%
2020-12-31	CA$13.91 Million ≈ $10.06 Million	CA$-13.97 Million ≈ $-10.11 Million	-1.004x	-54.28%
2019-12-31	CA$29.88 Million ≈ $21.61 Million	CA$-19.45 Million ≈ $-14.07 Million	-0.651x	-244.11%
2018-12-31	CA$26.38 Million ≈ $19.08 Million	CA$-4.99 Million ≈ $-3.61 Million	-0.189x	+92.54%
2017-12-31	CA$841.07K ≈ $608.42K	CA$-2.13 Million ≈ $-1.54 Million	-2.537x	-506.93%
2016-12-31	CA$-29.76K ≈ $-21.53K	CA$-18.55K ≈ $-13.42K	0.623x	--

About Avicanna Inc

TO:AVCN Canada Drug Manufacturers - Specialty & Generic

Market Cap

$13.17 Million

CA$18.21 Million CAD

Market Cap Rank

#26195 Global

#1072 in Canada

Share Price

CA$0.15

Change (1 day)

+0.00%

52-Week Range

CA$0.15 - CA$0.30

All Time High

CA$6.90